Next Investors logo grey

Markets falter ahead of voting on US healthcare legislation

Published 24-MAR-2017 08:47 A.M.


1 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

For the best part, global markets remained in a holding pattern awaiting the outcome of the House of Representatives vote on healthcare or ‘Trumpcare’ legislation, an important component of the Trump administration’s election win, and now a litmus test of whether the new government will be able to make the fiscal changes it has promised.

While there are different schools of thought as to whether the legislation will pass, markets appear to be getting increasingly pessimistic. The CBOE Volatility Index (VIX), commonly referred to as the ‘fear gauge’ increased 2.4% to its highest level in 2017.

Though the Dow was up approximately 100 points mid-session, all of those gains were lost plus some, as robust selling emerged in the last hour of trading.

It was also the last hour’s trading that brought the NASDAQ undone as it closed four points lower to finish at 5817 points.

The UK was taking its lead from the US, only increasing 0.2% to 7340 points despite positive retail sales figures being released.

However, there were some solid performances on mainland Europe with the DAX and the Paris CAC 40 increasing 1.1% and 0.8% respectively to close at 12,039 points and 5032 points.

The oil price continued to come under pressure, finishing close to its intraday low of US$47.58 per barrel after trading as high as US$48.48 per barrel.

Elsewhere on the commodities front, iron ore retrieved some of its recent loss ground, increasing 1.6% to US$86.36 per tonne.

Gold broke its winning streak, finishing 0.4% lower at US$1248 per ounce.

Base metals were mixed with copper up 0.8% and zinc coming off 1.1%. Nickel and lead were flat.

The Australian dollar is fetching US$0.763.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.